Furthermore, we also examined whether the Akt inhibitor can synergize with miR-329 in inhibiting proliferation in glioma cells, the levels of Akt phosphorylation are decreased by treatment with Akt inhibitor IV, in which the p21 is significantly increased and cyclin D1 is decreased. Here, AKT1 is linked to central nervous system cancer.